CIK 0001388320 · Non-accelerated filer<br>Smaller reporting company
Actinium Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ATNM
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880378336
- Phone
- (646) 677-3870
- Business address
- 100 PARK AVE., 23RD FLOOR, NEW YORK, NY, 10017
- Former names
- Cactus Ventures, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-31 | Shetty Ajit Director | Returned to the company · Stock Option (Right to Buy) | −2,500 | 0 | ||
| 2025-03-31 | Shetty Ajit Director | Returned to the company · Stock Option (Right to Buy) | −2,500 | 0 | ||
| 2025-03-31 | Shetty Ajit Director | Returned to the company · tock Option (Right to Buy) | −8,333 | 0 | ||
| 2025-03-31 | Shetty Ajit Director | Returned to the company · Stock Option (Right to Buy) | −8,333 | 0 | ||
| 2025-03-31 | Shetty Ajit Director | Returned to the company · Stock Option (Right to Buy) | −18,351 | 0 | ||
| 2025-03-31 | Shetty Ajit Director | Returned to the company · Stock Option (Right to Buy) | −72,156 | 0 | ||
| 2025-03-31 | Shetty Ajit Director | Returned to the company · Stock Option (Right to Buy) | −70,311 | 0 | ||
| 2025-03-31 | SETH SANDESH Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −16,666 | 0 | ||
| 2025-03-31 | SETH SANDESH Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −25,000 | 0 | ||
| 2025-03-31 | SETH SANDESH Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −33,333 | 0 | ||
| 2025-03-31 | SETH SANDESH Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −50,000 | 0 | ||
| 2025-03-31 | SETH SANDESH Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −139,062 | 0 | ||
| 2025-03-31 | SETH SANDESH Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −310,182 | 0 | ||
| 2025-03-31 | SETH SANDESH Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −827,366 | 0 | ||
| 2025-03-31 | SETH SANDESH Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −984,367 | 0 | ||
| 2025-03-31 | O'Loughlin Steve Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −3,333 | 0 | ||
| 2025-03-31 | O'Loughlin Steve Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −1,666 | 0 | ||
| 2025-03-31 | O'Loughlin Steve Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −3,333 | 0 | ||
| 2025-03-31 | O'Loughlin Steve Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −8,833 | 0 | ||
| 2025-03-31 | O'Loughlin Steve Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −13,333 | 0 |
Page 3 of 16 · 316 trades